EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

A multicenter, open-label extension study of gabapentin monotherapy in pediatric patients with benign epilepsy with centrotemporal spikes






Epilepsia 37(SUPPL 5): 111

A multicenter, open-label extension study of gabapentin monotherapy in pediatric patients with benign epilepsy with centrotemporal spikes



Accession: 029685285



Related references

Hes, M.S.; Trudeau, V.L.; Kilgore, M.B.; Poulter, C.J.; Garofalo, E.A.; Koto, E.P.; 94/95, U.S.G.p Study Group, 1995: A double-blind, placebo-controlled, randomized multicenter trial of GABAPENTIN in pediatric patients with benign childhood epilepsy with centrotemporal spikes. Epilepsia 36(SUPPL 4): 125

Bourgeois, B.; Brown, L.W.; Pellock, J.M.; Buroker, M.; Greiner, M.; Garofalo, E.A.; Schimschock, J.R.; Griesemer, D.; Bebin, M.E.; Murphy, J.V., 1998: Gabapentin monotherapy in children with benign childhood epilepsy with centrotemporal spikes A 36-week, double-blind, placebo-controlled study. Epilepsia 39(SUPPL 6): 163

Coppola, G.; Franzoni, E.; Verrotti, A.; Garone, C.; Sarajlija, J.; Operto, F.Felicia.; Pascotto, A., 2006: Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial. To evaluate the efficacy and tolerability of levetiracetam or oxcarbazepine as monotherapy in children with newly diagnosed benign epilepsy with centrotemporal spikes (BECTS). Twenty-one children (11 males, 10 females), aged between 5 and 13 years...

Anhut, H.; Greiner, M.J.; Alexander, J.; Murray, G.; 78/178, I.G.p Study Group, 1997: Gabapentin monotherapy compared with carbamazepine An international open-label multicenter study in patients with newly diagnosed epilepsy. Epilepsia 38(SUPPL 8): 92

Crockatt, J.G.; Leiderman, D.B.; Malicsi, M.J.R.; Garofalo, E.A.; 88 89, T.U.G.p Study Group, 1995: Open-label, follow-on study of Gabapentin monotherapy in patients with refractory epilepsy. Epilepsia 36(SUPPL 4): 69

Garofalo, E.A.; Hayes, A.G.; Greeley, C.A.; Hes, M.S.; Mann, M.E.; Pierce, M.W.; 82/83, T.U.G.p Study Group, 1995: An open-label extension study of GABApentin monotherapy in patients with medically refractory partial seizures. Epilepsia 36(SUPPL 4): 68

Hyayes, A.; Hes, M.; Mann, M.; Garofalo, E.; Leiderman, D.B.; Pierce, M., 1994: An open-label multicenter study of gabapentin monotherapy and safety in medically refractory patients with partial seizures. Neurology 44(4 SUPPL 2): A204

Rating, D.; Wolf, C.; Bast, T., 2000: Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: A 6-month randomized, double-blind, placebo-controlled study. Purpose: To evaluate the efficacy and tolerability of sulthiame (STM) as monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS). Methods: Sixty-six BECTS patients entered a 6-month double-blind trial and were ran...

Hayes, A.; Mann, M.; Greeley, C.; Hes, M.; Spring, P.; Garofalo, E.; Leiderman, D.; Pierce, M.; 82/83, T.U.G.bapentin Study Group, 1994: An ongoing open-label multicenter study evaluating gabapentin monotherapy and safety in patients with medically refractory partial seizures. Epilepsia 35(SUPPL 8): 164

Tzitiridou, M.; Panou, T.; Ramantani, G.; Kambas, A.; Spyroglou, K.; Panteliadis, C., 2005: Oxcarbazepine monotherapy in benign childhood epilepsy with centrotemporal spikes: a clinical and cognitive evaluation. We report on 70 patients (aged 5.2-11.6 years) newly diagnosed with benign childhood epilepsy with centrotemporal spikes (BECTS) who were assigned to oxcarbazepine (OXC) monotherapy. All of them underwent clinical and electroencephalographic exami...